LabGenius

About:

LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.

Website: http://www.labgeni.us

Twitter/X: labgeni_us

Top Investors: Innovate UK, Lux Capital, Felicis, Octopus Ventures, Atomico

Description:

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics.

Total Funding Amount:

$73.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2012-09-01

Contact Email:

hi(AT)labgeni.us

Founders:

Harry Rickerby, James Field

Number of Employees:

51-100

Last Funding Date:

2024-05-21

IPO Status:

Private

© 2024 MyAiNote.com